ArticleOpen life sciences2023

Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers.

Lan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.